In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍
Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database)
As AI enters care, transparency can’t lag
jamanetwork.com/journals/jam...
This study examines the extent and nature of payments made to health care professionals and teaching hospitals by manufacturers of FDA-authorized AI- and machine learning–enabled devices.